Aim & Scope
Molecular Biomedicine is a peer-reviewed, online open access, multidisciplinary journal that publishes the pioneer works of biomedicine, emphasizing on pathogenic mechanism and innovative techniques for diagnosis and therapy. This journal has an international authorship and a broad scope in basic, translational and clinical research including but not limited to: Epigenetics, genomics and proteomics; Gene editing; RNA biology; Signal transduction; Structural biology; Early diagnosis and biomarkers of disease; Gene therapy, cell therapy and immunotherapy; Targeted therapy by small molecules; Molecular imaging; Artificial intelligence in medicine; Regenerative medicine. [1]
2024 - VOLUME 5, ISSUE 1
UCHL5 is a putative prognostic marker in renal cell carcinoma: a study of UCHL family
M Zhang , J Li , S Liu , ... , L Zhang
Molecular Biomedicine , 2024 - VOLUME 5, ISSUE 1
Y Tao , L Wei , N Shiba , ... , H You
Molecular Biomedicine , 2024 - VOLUME 5, ISSUE 1 , p 1.
Biomaterials barcoding: a high-throughput breakthrough.
Molecular Biomedicine , 2024 - VOLUME 5, ISSUE 1 , p 2.
M Tao , Y Shi , H Chen , ... , N Liu
Molecular Biomedicine , 2024 - VOLUME 5, ISSUE 1 , p 3.
Unlocking γδ T cell power: pathways that boost cancer defense.
Molecular Biomedicine , 2024 - VOLUME 5, ISSUE 1 , p 5.
S Qu , R Xu , G Yi , ... , G Huang
Molecular Biomedicine , 2024 - VOLUME 5, ISSUE 1 , p 6.
Annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer.
A Woodward , B Southard , S Chakraborty , ... , RG Harrison
Molecular Biomedicine , 2024 - VOLUME 5, ISSUE 1 , p 7.
Structural and functional insights of NINJ1 in plasma membrane rupture during cell death.
Molecular Biomedicine , 2024 - VOLUME 5, ISSUE 1 , p 8.
L Zhang , P Liu , L Zhuang , ... , X Xu
Molecular Biomedicine , 2024 - VOLUME 5, ISSUE 1 , p 9.